Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.

Persistent disabling breathlessness in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2016) 0.81

Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95

Standardisation of spirometry. Eur Respir J (2005) 48.20

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J (2004) 16.84

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63

Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. N Engl J Med (2015) 4.16

Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest (2002) 3.82

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J (2008) 3.67

Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med (2012) 3.00

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. Eur Respir J (2005) 2.60

Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax (2009) 2.27

The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med (2011) 2.15

Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J (2008) 1.80

Longitudinal assessment in COPD patients: multidimensional variability and outcomes. Eur Respir J (2013) 1.49

Barriers to adherence to COPD guidelines among primary care providers. Respir Med (2011) 1.47

The quality of COPD care in general practice in Denmark: the KVASIMODO study. Prim Care Respir J (2007) 1.26

Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med (2004) 1.22

Diagnosis and management of chronic obstructive pulmonary disease (COPD) in a primary care clinic. COPD (2009) 1.08

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. Chest (2001) 0.96

Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting. Ther Adv Respir Dis (2013) 0.94

Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study. PLoS One (2014) 0.87

binGroup: A Package for Group Testing. R J (2010) 0.86

Prevalence of chronic obstructive pulmonary disease in the Canary Islands. Arch Bronconeumol (2014) 0.82

Prediction equations for forced spirometry from European origin populations. Barcelona Collaborative Group on Reference Values for Pulmonary Function Testing and the Spanish Group of the European Community Respiratory Health Survey. Respir Med (1998) 0.82

Inhaled steroids in COPD: when should they be used? Lancet Respir Med (2014) 0.79

The evaluation of general practitioners' awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburb. Asia Pac J Public Health (2013) 0.78